Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry
Robert A. Bittner, Andreas Reif, Mishal Qubad
Current Opinion in Psychiatry (2023) Vol. 36, Iss. 4, pp. 327-336
Open Access | Times Cited: 9

Showing 9 citing articles:

The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force
Hélène Verdoux, Robert A. Bittner, Alkomiet Hasan, et al.
European Psychiatry (2025), pp. 1-13
Open Access | Times Cited: 1
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 671-696
Open Access | Times Cited: 4
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN)
Marte Z. van der Horst, Nini de Boer, Ahmet Müderrisoğlu, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Two Long-Acting Antipsychotics in a Patient with Treatment-Resistant Schizophrenia: A Case Report
Salvatore Cipolla, Flora Delli Carpini, Pierluigi Catapano, et al.
Clinics and Practice (2025) Vol. 15, Iss. 3, pp. 55-55
Open Access
Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
André Luiz Schuh Teixeira, Olivia Sorato Bezerra, Luís Augusto Rohde, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 324-343
Closed Access | Times Cited: 1
Prevalence of treatment-resistant schizophrenia among people with early psychosis and its clinical and demographic correlates
Mirza Detanac, Chelsey Williams, Milan Dragović, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 12, pp. 1080-1089
Open Access | Times Cited: 1
Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2
Lily Van, Tracy Heung, Nikolai Gil D. Reyes, et al.
The Canadian Journal of Psychiatry (2024)
Closed Access | Times Cited: 1
Enhancing Predictive Power: Integrating a Linear Support Vector Classifier with Logistic Regression for Patient Outcome Prognosis in Virtual Reality Therapy for Treatment-Resistant Schizophrenia
Alexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 12, pp. 1660-1660
Open Access | Times Cited: 1
When, Why and How to Re-challenge Clozapine following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top